- Home
- SGMO vs PDCC Comparison
SGMO vs PDCC Comparison
Compare SGMO & PDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- PDCC
- Stock Information
- Founded
- SGMO 1995
- PDCC N/A
- Country
- SGMO United States
- PDCC
- Employees
- SGMO N/A
- PDCC N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- PDCC
- Sector
- SGMO Health Care
- PDCC
- Exchange
- SGMO Nasdaq
- PDCC NYSE
- Market Cap
- SGMO 122.8M
- PDCC 123.0M
- IPO Year
- SGMO 2000
- PDCC N/A
- Fundamental
- Price
- SGMO $0.46
- PDCC $17.02
- Analyst Decision
- SGMO Buy
- PDCC
- Analyst Count
- SGMO 6
- PDCC 0
- Target Price
- SGMO $4.50
- PDCC N/A
- AVG Volume (30 Days)
- SGMO 4.1M
- PDCC N/A
- Earning Date
- SGMO 08-05-2025
- PDCC N/A
- Dividend Yield
- SGMO N/A
- PDCC N/A
- EPS Growth
- SGMO N/A
- PDCC N/A
- EPS
- SGMO N/A
- PDCC N/A
- Revenue
- SGMO $63,756,000.00
- PDCC N/A
- Revenue This Year
- SGMO N/A
- PDCC N/A
- Revenue Next Year
- SGMO N/A
- PDCC N/A
- P/E Ratio
- SGMO N/A
- PDCC N/A
- Revenue Growth
- SGMO 239.92
- PDCC N/A
- 52 Week Low
- SGMO $0.30
- PDCC N/A
- 52 Week High
- SGMO $3.18
- PDCC N/A
- Technical
- Relative Strength Index (RSI)
- SGMO 38.27
- PDCC N/A
- Support Level
- SGMO $0.49
- PDCC N/A
- Resistance Level
- SGMO $0.51
- PDCC N/A
- Average True Range (ATR)
- SGMO 0.04
- PDCC 0.00
- MACD
- SGMO 0.01
- PDCC 0.00
- Stochastic Oscillator
- SGMO 6.25
- PDCC 0.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About PDCC PEARL DIVER CREDIT COMPANY INC
PEARL DIVER CREDIT COMPANY INC is an externally managed, non-diversified, closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation by investing predominantly in third-party Collateralized Loan Obligation (CLO) equity and mezzanine tranches of predominately U.S.-dollar-denominated CLOs backed by corporate leveraged loans issued mainly to U.S. obligors.